About a dozen lawsuits, citing 2024 studies, allege Ozempic causes a rare eye disorder that leads to irreversible blindness. ...

Novo Nordisk scored a legal win against compounders of its blockbuster GLP-1 drugs. But it may not end the copycats.

A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...

Novo Nordisk faces a suit claiming it failed to warn users of Ozempic of the danger of blindness. The suit is brought by a ...

The Food and Drug Administration had determined there is no longer a shortage of drugs like Ozempic and Wegovy, therefore it had set ending dates for the use of the compounded prescriptions made of ...

A Maryland man has filed a lawsuit against the manufacturers of Ozempic, alleging that his use of the drug led to him ...

Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found that tens of thousands of Americans have ended up in the emergency room from ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Novo Nordisk (NVO) won a key case Thursday to stop some compounding ... semaglutide — the active ingredient in diabetes drug Ozempic and weight-loss drug Wegovy — next month.